(210 days)
No
The description mentions a "diagnostic algorithm" for rhythm analysis, but there is no indication or mention of AI, ML, or related terms. The performance studies focus on compliance with established standards and equivalence to predicate devices, not on the performance of an AI/ML model.
Yes
The device is designed for emergency treatment of cardiac arrest by delivering a defibrillation shock to terminate potentially fatal arrhythmias, which definitively constitutes a therapeutic purpose.
Yes
The "Device Description" section states that "The device's diagnostic algorithm analyzes the patient's cardiac rhythm to determine shockable versus non-shockable EKG rhythm." This indicates its function involves diagnosis.
No
The device description clearly outlines physical hardware components such as a battery, user button, LED panel, and voice prompts, and provides physical dimensions and weight. It also mentions hardware testing in the performance studies section.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The FirstSave STAR Biphasic AED is a defibrillator. Its function is to deliver an electrical shock to the patient's chest to restore a normal heart rhythm. It analyzes the patient's cardiac rhythm in vivo (within the living body) using electrodes placed on the skin.
- Lack of Specimen Analysis: The description clearly states the device analyzes the patient's cardiac rhythm directly. There is no mention of collecting or analyzing any specimens from the patient.
Therefore, based on the provided information, the FirstSave STAR Biphasic AED is a therapeutic device used for emergency treatment of cardiac arrest, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The SurVivaLink's FirstSave STAR Biphasic AED is designed for emergency treatment of cardiac arrest by trained personnel to terminate potentially fatal arrhythmias for patients older than eight years old. The user assesses the patient's condition and confirms that the patient is unconscious, pulseless and is not breathing prior to use of the device.
The FirstSave STAR Biphasic AED is intended for use by or on the order of a Physician or persons licensed by State law. It is designed for emergency treatment of cardiac arrest patients by trained personnel. The user assesses the patient's condition and confirms that the patient is unconscious, pulseless and is not breathing prior to use of the device. The FirstSave STAR Biphasic AED is intended to be used on patients older than eight years'.
Product codes
74 MKJ
Device Description
The FirstSave STAR Biphasic AED is a portable battery operated semi-automatic low power DC defibrillator. The device's diagnostic algorithm analyzes the patient's cardiac rhythm to determine shockable versus non-shockable EKG rhythm. The operator then pushes the button to deliver the defibrillation shock. The FirstSave STAR Biphasic AED feature includes:
- Biphasic defibrillation waveform
- Lithium battery and battery fuel gauge
- Single user button
- LED diagnostic panel
- Non-volatile status indicator
- Voice prompts
The device weighs 7.4 lbs including battery, and electrodes with dimensions of 3.3in x 10.6in x 12.4in.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
patients older than eight years old.
patients older than eight years'.
Intended User / Care Setting
trained personnel
Physician or persons licensed by State law.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The performance test data is provided in the 510(k) submission. The performance data demonstrate that the device complies with the applicable sections of AAMI DF39-1993 and AAMI DF2-1996. The device was developed under design control and the hardware and software tested in accordance with established industry standards.
Tests results include rhythm detection, EMC, charge time, pulse shape, battery capacity, defibrillation recovery, design verification and validation data for hardware and software incorporated into the FirstSave STAR Biphasic AED. Environmental tests were performed on the finished device.
Clinical studies was performed to test the efficacy of the biphasic waveform in the FirstSave STAR Biphasic AED device and was found to be equivalent to the monophasic truncated exponential waveform in the FirstSave.
Test data demonstrate that the safety and effectiveness of the FirstSave STAR Biphasic AED are substantially equivalent to the HeartStream's Forerunner and the SurVivaLink's FirstSave AEDs.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5310 Automated external defibrillator system.
(a)
Identification. An automated external defibrillator (AED) system consists of an AED and those accessories necessary for the AED to detect and interpret an electrocardiogram and deliver an electrical shock (e.g., battery, pad electrode, adapter, and hardware key for pediatric use). An AED system analyzes the patient's electrocardiogram, interprets the cardiac rhythm, and automatically delivers an electrical shock (fully automated AED), or advises the user to deliver the shock (semi-automated or shock advisory AED) to treat ventricular fibrillation or pulseless ventricular tachycardia.(b)
Classification. Class III (premarket approval)(c)
Date PMA or notice of completion of PDP is required. A PMA will be required to be submitted to the Food and Drug Administration by April 29, 2015, for any AED that was in commercial distribution before May 28, 1976, or that has, by April 29, 2015, been found to be substantially equivalent to any AED that was in commercial distribution before May 28, 1976. A PMA will be required to be submitted to the Food and Drug Administration by April 29, 2015, for any AED accessory described in paragraph (a) that was in commercial distribution before May 28, 1976, or that has, by April 29, 2015, been found to be substantially equivalent to any AED accessory described in paragraph (a) that was in commercial distribution before May 28, 1976. Any other AED and AED accessory described in paragraph (a), shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
0
JAN 25 1999
510(k) Summary
ADMINSTRATIVE INFORMATION L-1.
L-1.1 Name and address
SurVivaLink Corporation Submitted by: 5430 Feltl Road Minneapolis, MN 55343
| Contact Person: | Sew-Wah Tay, Ph.D. |
|---|---|
| Telephone No.: | 612-939-2942 |
| Facsimile No.: | 612-939-4191 |
June 24, 1998 Date Prepared:
L-1.2 Device Name
Common or Usual Name: Semi-Automatic External Defibrillator (AED) Device Name: FirstSave™ STAR Biphasic™ AED
L-1.3 Classification
Classification Name: a) DC defibrillator
21CFR&870.5300; Class II
b) Cardiac Monitor (Cardiotachometer and Rate Alarm) 21CFR§870.2300; Class II
Note: FDA has determined that Semi-Automatic External Defibrillators are currently classified as class III devices
L-1.4 Applicant
Applicant's Name: SurVivaLink, Corporation 5430 Feltl Road Minneapoils, MN 55343
L-2. PREDICATE DEVICE
FirstSave™ AED manufactured by SurVivaLink Corporation models 9100/9110 (K970481) and Forerunner AED manufactured by HeartStream models S, E and EM (K955628).
L-3. INDICATION FOR USE
The SurVivaLink's FirstSave STAR Biphasic AED is designed for emergency treatment of cardiac arrest by trained personnel to terminate potentially fatal arrhythmias for patients older than eight years old. The user assesses the patient's condition and confirms that the patient is unconscious, pulseless and is not breathing prior to use of the device.
1
DEVICE DESCRIPTION L-4
The FirstSave STAR Biphasic AED is a portable battery operated semi-automatic low power DC defibrillator. The device's diagnostic algorithm analyzes the patient's cardiac rhythm to determine shockable versus non-shockable EKG rhythm. The operator then pushes the button to deliver the defibrillation shock. The FirstSave STAR Biphasic AED feature includes:
- . Biphasic defibrillation waveform
- . Lithium battery and battery fuel gauge
- Single user button .
- LED diagnostic panel ●
- Non-volatile status indicator ●
- Voice prompts .
The device weighs 7.4 lbs including battery, and electrodes with dimensions of 3.3in x 10.6in x 12.4in.
PERFORMANCE DATA L-5.
The performance test data is provided in the 510(k) submission. The performance data demonstrate that the device complies with the applicable sections of AAMI DF39-1993 and AAMI DF2-1996. The device was developed under design control and the hardware and software tested in accordance with established industry standards.
Tests results include rhythm detection, EMC, charge time, pulse shape, battery capacity, defibrillation recovery, design verification and validation data for hardware and software incorporated into the FirstSave STAR Biphasic AED. Environmental tests were performed on the finished device.
Clinical studies was performed to test the efficacy of the biphasic waveform in the FirstSave STAR Biphasic AED device and was found to be equivalent to the monophasic truncated exponential waveform in the FirstSave.
Test data demonstrate that the safety and effectiveness of the FirstSave STAR Biphasic AED are substantially equivalent to the HeartStream's Forerunner and the SurVivaLink's FirstSave AEDs.
L-6 SUBSTANTIAL EQUIVALENCE
The FirstSave STAR Biphasic AED is a portable, battery powered, semi-automatic, low energy DC external defibrillator. The materials, accessories and user interfaces are identical to the FirstSave AED (K970481).
The Company's FirstSave STAR Biphasic AED covered by this submission is substantially equivalent to other legally marketed semi-automatic low power DC
2
defibrillators. Specifically, the FirstSave STAR Biphasic AED is substantially equivalent to the SurVivaLink's FirstSave and the HeartStream Forerunner AED. The FirstSave STAR Biphasic AED has the same general indication for use, similar principles of operation, and similar technological characteristics as the previously cleared Forerunner and FirstSave devices. Although there are minor differences in the characteristics of the FirstSave STAR Biphasic AED and its predicate devices, those differences do not raise new questions of safety or efficacy.
的人物的人物的人物
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, featuring a staff with three intertwined snakes.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 25 1999
Sew-Wah Tay, Ph.D. SurVivaLink Corporation 5420 Feltl Road Minneapolis, MN 55343
K982264 Re: FirstSave STAR Biphasic Regulatory Class: III (three) Product Code: 74 MKJ November 13, 1998 Dated: November 16, 1998 Received:
Dear Dr. Tay:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. You may, therefore, market the device, subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act). The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under section 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws or Regulations.
4
Page 2 - Sew-Wah Tay, Ph.D.
On August 16, 1993 the Final Rule for Device Tracking was published in the Federal Register, pages 43442-43455 (copy enclosed). Be advised that under Section 519(e) of the Act as amended by the Safe Medical Devices Act of 1990, FDA has identified the above device as a device which requires tracking. Because the device is subject to tracking, you are required to adopt a method of tracking that follows the devices throuqh the distribution chain and then identifies and follows the patients who receive them. The specific requirements of the requlation are found in 21 CFR 821 as described in the August 16, 1993 Federal Register beginning on page 43447.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please not the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act, may be obtained from the Division of Small Manufacturers Assistance at its toll free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Arle A. Cich.
Yo Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosures
5
510(k) Number : K982264
Device Name: FirstSave STAR Biphasic AED
Indication For Use
The FirstSave STAR Biphasic AED is intended for use by or on the order of a Physician or persons licensed by State law. It is designed for emergency treatment of cardiac arrest patients by trained personnel. The user assesses the patient's condition and confirms that the patient is unconscious, pulseless and is not breathing prior to use of the device. The FirstSave STAR Biphasic AED is intended to be used on patients older than eight years'.
Marle Kramer
PRESCRIPTION USE
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices
510(k) Number _
1 American Heart Association (1994): "Advanced Cardiac Life Support" Ed by R.O. Cummins. pp 4-11.